@article{8e438763132d4a27a46fdef63ad4e5ae,
title = "Randomized Phase II Study of Two Schedules of Flavopiridol (Alvocidib, F) Given as Timed Sequential Therapy (TST) Wtih Ara-C and Mitoxantrone (FLAM) for Adults with Newly Diagnosed, Poor-Risk Acute Myelogenous Leukemia (AML)",
author = "Karp, \{Judith E.\} and Pagel, \{John M.\} and Smith, \{B. Douglas\} and Greer, \{Jacqueline M\} and Drye, \{D. Michelle\} and Smith, \{Kelly M.\} and Kathleen Dorcy and Wright, \{John J\} and Doyle, \{L. Austin\} and Elizabeth Garrett-Mayer and Estey, \{Elihu H.\}",
note = "Abstract 186 Acute Myeloid Leukemia - Therapy, excluding Transplantation: Pediatric and Adult AML Therapy F is a protein bound, cytotoxic, cyclin dependent kinase inhibitor.",
year = "2010",
month = nov,
day = "19",
language = "American English",
volume = "116",
journal = "Blood",
}